Literature DB >> 14161913

A CONTROLLED COMPARISON OF STREPTOMYCIN PLUS PYRAZINAMIDE AND STREPTOMYCIN PLUS PAS IN THE RETREATMENT OF PATIENTS EXCRETING ISONIAZID-RESISTANT ORGANISMS.

S VELU, J J DAWSON, S DEVADATTA, W FOX, K G KULKARNI, K MOHAN, C V RAMAKRISHNAN, H STOTT.   

Abstract

Entities:  

Keywords:  AMINOSALICYLIC ACID; BACTERIOLOGY; CLINICAL RESEARCH; DRUG RESISTANCE, MICROBIAL; INDIA; ISONIAZID; PYRAZINAMIDE; SPUTUM; STREPTOMYCIN; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY

Mesh：

Substances：

Year:  1964        PMID： 14161913     DOI： 10.1016/s0041-3879(64)80072-6

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  4 in total

1.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

2.  ACONCURRENT COMPARISON OF INTERMITTENT (TWICE-WEEKLY) ISONIAZID PLUS STREPTOMYCIN AND DAILY ISONIAZID PLUS PAS IN THE DOMICILIARY TREATMENT OF PULMONARY TUBERCULOSIS; TUBERCULOSIS CHEMOTHERAPY CENTRE, MADRAS.

Authors:  A LOTTE; F HATTON; S PERDRIZET; A ROUILLON
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

3.  A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone.

Authors:  C Evans; S Devadatta; W Fox; P R Gangadharam; N K Menon; C V Ramakrishnan; S Sivasubramanian; P R Somasundaram; H Stott; S Velu
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

Review 4.  What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis.

Authors:  H R Stagg; R J Harris; H-A Hatherell; D Obach; H Zhao; N Tsuchiya; K Kranzer; V Nikolayevskyy; J Kim; M C Lipman; I Abubakar
Journal:  Thorax       Date:  2016-06-13       Impact factor: 9.139
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.